• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Pragmatic measurement of health satisfaction in people with type 2 diabetes mellitus using the Current Health Satisfaction Questionnaire.使用当前健康满意度问卷对2型糖尿病患者的健康满意度进行实用测量。
Patient Relat Outcome Meas. 2015 Mar 26;6:103-15. doi: 10.2147/PROM.S79368. eCollection 2015.
2
The Diabetes Intention, Attitude, and Behavior Questionnaire: evaluation of a brief questionnaire to measure physical activity, dietary control, maintenance of a healthy weight, and psychological antecedents.糖尿病意向、态度和行为问卷:一份用于测量身体活动、饮食控制、维持健康体重及心理前因的简短问卷的评估
Patient Prefer Adherence. 2016 Feb 29;10:213-22. doi: 10.2147/PPA.S94878. eCollection 2016.
3
Psychometric properties of the Greek Diabetes Treatment Satisfaction Questionnaire.希腊版糖尿病治疗满意度问卷的心理测量学特性。
Health Qual Life Outcomes. 2012 Feb 1;10:17. doi: 10.1186/1477-7525-10-17.
4
CANadian CAnagliflozin REgistry: Patient-Reported Outcomes of Canagliflozin in the Treatment of Type 2 Diabetes Mellitus in Canadian Clinical Practice.CANadian CAnagliflozin REgistry:加拿大卡格列净登记研究:卡格列净治疗加拿大临床实践中 2 型糖尿病患者的患者报告结局。
Can J Diabetes. 2019 Oct;43(7):464-471. doi: 10.1016/j.jcjd.2019.04.004. Epub 2019 Apr 16.
5
Psychometric Evaluation of the Hypogonadism Impact of Symptoms Questionnaire Short Form (HIS-Q-SF).性腺功能减退症状问卷简表(HIS-Q-SF)的心理测量学评估
J Sex Med. 2017 Aug;14(8):1046-1058. doi: 10.1016/j.jsxm.2017.05.013.
6
Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9.对于新诊断的糖化血红蛋白(HbA1c)>9%的 2 型糖尿病患者,短期强化胰岛素治疗可能是首选。
J Diabetes. 2017 Oct;9(10):890-893. doi: 10.1111/1753-0407.12581. Epub 2017 Aug 22.
7
[Validation of the QFS measuring the frequency and satisfaction in social behaviours in psychiatric adult population].[用于评估成年精神病患者社交行为频率与满意度的QFS量表的验证]
Encephale. 2006 Jan-Feb;32(1 Pt 1):45-59. doi: 10.1016/s0013-7006(06)76136-x.
8
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
9
[Psychometric characteristics of questionnaires designed to assess the knowledge, perceptions and practices of health care professionals with regards to alcoholic patients].[旨在评估医护人员对酒精依赖患者的知识、认知及实践情况的调查问卷的心理测量学特征]
Encephale. 2004 Sep-Oct;30(5):437-46. doi: 10.1016/s0013-7006(04)95458-9.
10
Review of patient-reported outcome instruments measuring health-related quality of life and satisfaction in patients with type 2 diabetes treated with oral therapy.对测量接受口服治疗的2型糖尿病患者健康相关生活质量和满意度的患者报告结局工具的综述。
Curr Med Res Opin. 2015 Apr;31(4):643-65. doi: 10.1185/03007995.2015.1020364. Epub 2015 Mar 16.

引用本文的文献

1
Association of SGLT-2 Inhibitors With Treatment Satisfaction and Diabetes-Specific and General Health Status in Adults With Cardiovascular Disease and Type 2 Diabetes.钠-葡萄糖共转运蛋白 2(SGLT-2)抑制剂与伴有心血管疾病和 2 型糖尿病的成年人的治疗满意度以及糖尿病特异性和一般健康状况的相关性。
J Am Heart Assoc. 2023 Sep 5;12(17):e029058. doi: 10.1161/JAHA.122.029058. Epub 2023 Sep 1.
2
Development of a Patient-Reported Outcome (PRO) Measure to Assess Emotional Impact of Treatment for Type 2 Diabetes.一种用于评估2型糖尿病治疗对情绪影响的患者报告结局(PRO)指标的开发。
Diabetes Ther. 2023 Sep;14(9):1451-1470. doi: 10.1007/s13300-023-01426-0. Epub 2023 Jun 23.
3
The Determinants of Living with Long-Term Conditions: An International Cross-Sectional Study.长期患病者生存状况的决定因素:一项国际横断面研究。
Int J Environ Res Public Health. 2021 Oct 2;18(19):10381. doi: 10.3390/ijerph181910381.
4
Measurement Properties of Patient-Reported Outcome Measures for Diabetes: Systematic Review.糖尿病患者报告结局测量量表的测量特性:系统评价。
J Med Internet Res. 2021 Aug 13;23(8):e25002. doi: 10.2196/25002.
5
Patient-Reported Experience and Outcome Measures in People Living with Diabetes: A Scoping Review of Instruments.糖尿病患者报告的体验和结局测量指标:工具的范围综述。
Patient. 2021 Nov;14(6):759-773. doi: 10.1007/s40271-021-00526-y. Epub 2021 May 27.
6
Real-world evidence in patient-reported outcomes (PROs) of metastatic castrate-resistant prostate cancer (mCRPC) patients treated with abiraterone acetate + prednisone (AA+P) across Canada: Final results of COSMiC.加拿大各地接受醋酸阿比特龙+泼尼松(AA+P)治疗的转移性去势抵抗性前列腺癌(mCRPC)患者的患者报告结局(PROs)的真实世界证据:COSMiC的最终结果。
Can Urol Assoc J. 2020 Dec;14(12):E616-E620. doi: 10.5489/cuaj.6388.
7
Patient-Reported Outcome Measures in Registry-Based Studies of Type 2 Diabetes Mellitus: a Systematic Review.基于注册的 2 型糖尿病研究中的患者报告结局测量:系统评价。
Curr Diab Rep. 2019 Nov 20;19(11):135. doi: 10.1007/s11892-019-1265-8.
8
A call to action to inform patient-centred approaches to obesity management: Development of a disease-illness model.呼吁采取行动,为以患者为中心的肥胖管理方法提供信息:疾病-病症模型的开发
Clin Obes. 2019 Jun;9(3):e12309. doi: 10.1111/cob.12309. Epub 2019 Apr 11.
9
Impact of Canagliflozin Treatment on Health-Related Quality of Life among People with Type 2 Diabetes Mellitus: A Pooled Analysis of Patient-Reported Outcomes from Randomized Controlled Trials.卡格列净治疗对 2 型糖尿病患者健康相关生活质量的影响:来自随机对照试验的患者报告结局的汇总分析。
Patient. 2018 Jun;11(3):341-352. doi: 10.1007/s40271-017-0290-4.
10
The association of weight loss with patient experience and outcomes in a population of patients with type 2 diabetes mellitus prescribed canagliflozin.在使用卡格列净治疗的2型糖尿病患者群体中,体重减轻与患者体验及预后的关联。
Diabetes Metab Syndr Obes. 2017 Mar 20;10:89-99. doi: 10.2147/DMSO.S129824. eCollection 2017.

本文引用的文献

1
The EORTC emotional functioning computerized adaptive test: phases I-III of a cross-cultural item bank development.欧洲癌症研究与治疗组织情绪功能计算机自适应测试:跨文化题库开发的第一至三阶段
Psychooncology. 2014 Apr;23(4):397-403. doi: 10.1002/pon.3427. Epub 2013 Nov 11.
2
Adults with greater weight satisfaction report more positive health behaviors and have better health status regardless of BMI.体重满意度较高的成年人报告称有更积极的健康行为,且无论身体质量指数如何,其健康状况都更好。
J Obes. 2013;2013:291371. doi: 10.1155/2013/291371. Epub 2013 Jun 3.
3
Sick but satisfied: the impact of life and health satisfaction on choice between health scenarios.生病但满意:生活和健康满意度对健康方案选择的影响。
J Health Econ. 2013 Jul;32(4):708-14. doi: 10.1016/j.jhealeco.2013.04.002.
4
Psychometric validation of the Self-Care Inventory-Revised (SCI-R) in UK adults with type 2 diabetes using data from the AT.LANTUS Follow-on study.使用 AT.LANTUS 随访研究的数据对英国 2 型糖尿病成人患者的自我护理量表修订版(SCI-R)进行心理测量学验证。
Health Qual Life Outcomes. 2013 Feb 26;11:24. doi: 10.1186/1477-7525-11-24.
5
How does illness severity influence depression, health satisfaction and life satisfaction in patients with cardiovascular disease? The mediating role of illness perception and self-efficacy beliefs.疾病严重程度如何影响心血管疾病患者的抑郁、健康满意度和生活满意度?疾病认知和自我效能信念的中介作用。
Psychol Health. 2013;28(7):765-83. doi: 10.1080/08870446.2012.759223. Epub 2013 Jan 24.
6
Determinants of satisfaction with individual health in male and female patients with chronic low back pain.慢性下背痛男性和女性患者对个体健康满意度的决定因素。
J Rehabil Med. 2012 Jul;44(8):658-63. doi: 10.2340/16501977-1010.
7
Quality of life in colorectal cancer patients with diarrhoea after surgery: a longitudinal study.结直肠癌术后腹泻患者的生活质量:一项纵向研究。
J Clin Nurs. 2012 Aug;21(15-16):2357-66. doi: 10.1111/j.1365-2702.2011.04034.x. Epub 2012 May 28.
8
Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).2型糖尿病高血糖管理:以患者为中心的方法:美国糖尿病协会(ADA)和欧洲糖尿病研究协会(EASD)的立场声明
Diabetes Care. 2012 Jun;35(6):1364-79. doi: 10.2337/dc12-0413. Epub 2012 Apr 19.
9
Dose-ranging effects of canagliflozin, a sodium-glucose cotransporter 2 inhibitor, as add-on to metformin in subjects with type 2 diabetes.卡格列净(钠-葡萄糖共转运蛋白 2 抑制剂)作为二线治疗药物与二甲双胍联用在 2 型糖尿病患者中的剂量范围效应。
Diabetes Care. 2012 Jun;35(6):1232-8. doi: 10.2337/dc11-1926. Epub 2012 Apr 9.
10
Helping patients with chronic conditions overcome barriers to self-care.帮助慢性病患者克服自我护理的障碍。
Nurse Pract. 2012 Mar 13;37(3):32-8; quiz 38-9. doi: 10.1097/01.NPR.0000411104.12617.64.

使用当前健康满意度问卷对2型糖尿病患者的健康满意度进行实用测量。

Pragmatic measurement of health satisfaction in people with type 2 diabetes mellitus using the Current Health Satisfaction Questionnaire.

作者信息

Traina Shana B, Colwell Hilary H, Crosby Ross D, Mathias Susan D

机构信息

Janssen Global Services, LLC, Raritan, NJ, USA.

Health Outcomes Solutions, Winter Park, FL, USA.

出版信息

Patient Relat Outcome Meas. 2015 Mar 26;6:103-15. doi: 10.2147/PROM.S79368. eCollection 2015.

DOI:10.2147/PROM.S79368
PMID:25870519
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4381897/
Abstract

BACKGROUND

The concept of diabetes-related health satisfaction encompasses issues specifically related to living with diabetes (eg, blood glucose, blood pressure levels, body weight). Health satisfaction is more specific than overall health-related quality of life because it considers disease-related factors, and is different from diabetes treatment satisfaction because it addresses issues not specifically related to treatment. Low levels of health satisfaction in people with type 2 diabetes mellitus (T2DM) may negatively affect self-care behaviors and treatment outcomes; however, there are currently no instruments available to assess health satisfaction in this population. This study assessed the measurement properties of a newly constructed, 14-item Current Health Satisfaction Questionnaire (CHES-Q) designed to assess diabetes-related health satisfaction and knowledge of the disease and important laboratory results.

METHODS

In-depth interviews were conducted in 23 adults with T2DM to confirm the content and clarity of the CHES-Q. The revised instrument was administered to 1,015 individuals with T2DM, along with supplemental questionnaires, including the Short Form-36. All subjects completed the questionnaires again 3 to 7 days later. CHES-Q test-retest reliability, construct validity, and known-groups validity were evaluated.

RESULTS

In general, respondents found the CHES-Q to be clear and comprehensive. Test-retest reliability was generally acceptable for all items (≥0.70), except for three that fell just below the widely accepted cut-point of 0.70 (range 0.63-0.69). Convergent and divergent validity was demonstrated based on hypothesized correlations with the Short Form-36. Known-groups validity was confirmed for most CHES-Q items when respondents were split into groups known to differ clinically by body mass index, disease severity, or glycated hemoglobin.

CONCLUSION

Health satisfaction is a unique and important concept to consider when developing individualized strategies for managing T2DM because health satisfaction is a key element of patient-centered care. The CHES-Q allows for the pragmatic assessment of many aspects of diabetes-related health satisfaction in a single questionnaire.

摘要

背景

糖尿病相关健康满意度的概念涵盖了与糖尿病生活相关的特定问题(如血糖、血压水平、体重)。健康满意度比总体健康相关生活质量更具针对性,因为它考虑了与疾病相关的因素,并且与糖尿病治疗满意度不同,因为它涉及的问题并非专门与治疗相关。2型糖尿病(T2DM)患者的健康满意度较低可能会对自我护理行为和治疗结果产生负面影响;然而,目前尚无用于评估该人群健康满意度的工具。本研究评估了新构建的、包含14个条目的当前健康满意度问卷(CHES-Q)的测量属性,该问卷旨在评估糖尿病相关健康满意度以及对疾病和重要实验室检查结果的了解情况。

方法

对23名成年T2DM患者进行了深入访谈,以确认CHES-Q的内容和清晰度。将修订后的问卷发放给1015名T2DM患者,并同时发放包括简短健康调查问卷-36(Short Form-36)在内的补充问卷。所有受试者在3至7天后再次完成问卷。评估了CHES-Q的重测信度、结构效度和已知组效度。

结果

总体而言,受访者认为CHES-Q清晰且全面。除了三个略低于广泛接受的0.70切点(范围为0.63 - 0.69)的条目外,所有条目的重测信度一般均可接受(≥0.70)。基于与简短健康调查问卷-36的假设相关性,证明了聚合效度和区分效度。当根据体重指数、疾病严重程度或糖化血红蛋白在临床上已知存在差异的分组对受访者进行划分时,大多数CHES-Q条目的已知组效度得到了证实。

结论

在制定T2DM个体化管理策略时,健康满意度是一个独特且重要的概念需要考虑,因为健康满意度是以患者为中心的护理的关键要素。CHES-Q允许在单一问卷中对糖尿病相关健康满意度的多个方面进行实际评估。